Sana Biotechnology Inc (NAS:SANA)
$ 3.39 -0.37 (-9.84%) Market Cap: 754.16 Mil Enterprise Value: 678.94 Mil PE Ratio: 0 PB Ratio: 2.22 GF Score: 36/100

Sana Biotechnology Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 11:45PM GMT
Release Date Price: $3.92 (+4.81%)
Tessa Thomas Romero
JPMorgan Chase & Co, Research Division - Associate

Welcome, everyone, to the 41st Annual JPMorgan Healthcare Conference. My name is Tessa Romero. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Taylor Hanley and Adhiraj Chauhan from the team.

Our next presenting company is Sana, and speaking on behalf of the company, we have CEO, Steve Harr. Before I turn it over to Steve, I just wanted to highlight that for Q&A after the formal presentation, there is an Ask a Question button in the portal, which should allow you to submit your questions, and I'm happy to ask the question on your behalf. We are also taking live questions here in the audience.

So just wave your hand and we'll get your question in.

So with that, I'm going to hand it over to Steve.

Steven D. Harr
Sana Biotechnology, Inc. - President, CEO & Director

Well, thank you, Tessa, and thank you, JPMorgan. Thank you everybody here in the audience as well as online for joining us. We're thrilled to have a chance to tell

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot